This seminar is hosted by the Oxford Martin Programme on Vaccines and the Jenner Institute
Speaker: Jan ter Meulen, MD, Dr.habil., DTM&H, Chief Scientific Officer, ImmuneDesign
Venue: Seminar Room, NDM Research Building
"Development of a DC-SIGN targeting integration deficient lentiviral vector for therapeutic vaccination in cancer and chronic infectious disease" by Dr Jan ter Meulen
Past Event